EC Healthcare
UNHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $3 |
| % Growth | -1.7% | 8.7% | 32.7% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $3 | $4 | $3 | $3 |
| % Margin | 80.7% | 84.2% | 85.7% | 88% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | $3 | -$0 | -$0 |
| Operating Expenses | $3 | $3 | $3 | $2 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 2.3% | 2.6% | 5.6% | 12.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -4% | -0.4% | 1.8% | 6.8% |
| EPS | -0.14 | -0.016 | 0.059 | 0.17 |
| % Growth | -775% | -127.1% | -65.3% | – |
| EPS Diluted | -0.14 | -0.016 | 0.059 | 0.17 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 15% | 17.7% | 20.3% | 27.5% |